| INTRODUCTION
Severe aortic stenosis (AS) is a leading cause of morbidity and mortality in the elderly adults. 1 Transcatheter aortic valve implantation (TAVI) has emerged as a promising therapeutic intervention in patients with prohibitive-, high-, and intermediate-risk for surgical aortic valve replacement for severe AS. [2] [3] [4] In the current era of cost containment, there is a concerted push for adopting a minimalist strategy in the TAVI patient population periprocedurally. 5 Constituent components of minimalist strategy generally include the following: preference for conscious sedation; transfemoral access; limiting the utility of transeophageal echocardiogram intraprocedurally; and early hospital discharge. 5 Traditionally, a significant number of patients are kept in the hospital for prolonged monitoring ostensibly more from an abundance of caution than for valid clinical reasons, thus, adding significantly to the costs of hospitalization. 6 Recent European studies have demonstrated the feasibility and safety of early hospital discharge after J Interven Cardiol. 2017;30:149-155. wileyonlinelibrary.com/journal/joic transfemoral TAVI. 6, 7 Understanding existing nationwide discharge patterns post-TAVI is critical in order to improve early hospital discharge percentage. However, systematic studies on discharge trends post TAVI are lacking in the United States.
The primary objective of our study was to identify predictors of early hospital discharge. Secondary objectives were: (i) Compare in-hospital outcomes and healthcare resource utilization in early versus late discharge cohorts; (ii) Ascertain the relationship between costs of hospitalization and length of stay, in TAVI. 
| Outcomes
Similar to prior studies, 6, 7 we defined "early discharge" as day of discharge ≤3 days post-TAVI and "late discharge" as day of discharge >3 days post-TAVI. We compared in-hospital outcomes related to TAVI, such as postoperative bleeding, blood transfusions, stroke or transient ischemic attacks (TIA), acute kidney injury (AKI), use of mechanical circulatory support, permanent pacemakers, valvuloplasty, length of hospitalization, and costs between early discharge and late discharge cohorts. ICD-9-CM codes were utilized to determine these outcomes (Supplementary Table) . Multivariate models were created to identify various factors and outcomes associated with early discharge.
Association of hospitalization costs (estimate of charges billed by the hospital) and post-TAVI length of stay was also analyzed. Elixhauser comorbidity score was used to measure severity of comorbidity burden. 10 NIS database contains completely de-identified data, which precludes need for institutional review board approval. were complete for all variables except race (6.3%) and median income (1.3%). We therefore, performed multiple imputations using the 3 | RESULTS
| Statistical analysis

| Baseline characteristics
Early discharge and late discharge cohorts consisted of 1557 and 5764 procedures, respectively. Mean age of overall cohort was 81 years.
Study comprised of 48% females and 84.5% whites. Elixhauser comorbidity score was lower in early discharge cohort (2.8 vs 3.2).
Approximately 85% of procedures were in 2012 and 83% were via transfemoral approach (Table 1) .
| In-hospital outcomes
Approximately 21% of patients were discharged in ≤3 days after TAVI. approximately 85% were discharged home, but among late discharge cohort; about 40% were discharged to extended care facilities/nursing homes ( Fig. 2 ). Early discharge rates improved from 11% in 2011 to 22% in 2012 ( Fig. 3) . Only 5% of patients who underwent transapical TAVI were discharged early as opposed to 25% among transfemoral cohort (Fig. 4) .
TAVI related complications such as post-operative bleeding, stroke or TIA, need for blood transfusions, AKI, use of mechanical circulatory support (intra-aortic balloon pump, extracorporeal membrane oxygenation, Impella, Tandem Heart, cardiopulmonary bypass), new permanent pacemaker implants were significantly higher in late discharge cohort (Table 2) . However, pre-TAVI aortic valvuloplasty was performed more often in early discharge cohort. Mean length of stay post-TAVI (7.7 days vs 2.6 days) and total hospital charges ($208 752 vs $157 663) were significantly higher in late discharge than early discharge cohort (Table 2 ).
| Predictors of early discharge
Multivariate predictors that were significantly associated with lower likelihood for early discharge were: females (adjusted OR: 2.51-9.17; P < 0.001) prior aortic valvuloplasty (adjusted OR: 2.40;
95%CI: 1.00-5.87; P = 0.04) were associated with higher odds for early discharge (Table 3) . However, prior aortic valvuloplasty, transfemoral TAVI approach, year of procedure were significantly associated with higher adjusted odds of early discharge. Lastly, we observed a strong positive correlation between costs of hospitalization and length of stay after TAVI.
At 30 days follow-up, bleeding complications were seen in 22.5% patients after TAVI in PARTNER trial. 11 However, post-operative bleeding rate during index hospitalization was much lower at 9.2% in our study. The stark difference in rate of bleeding complications is probably due to longer period of follow-up in former study. In addition,
we noted significant association of post-operative bleeding with lower odds of early discharge consistent with prior reports. 6, 7 Bleeding events requiring transfusions were threefold higher in the late discharge cohort and a strong predictor of lower early discharge rates in our study, congruent with prior work. 7, 12 Similarly, AKI was noted more commonly in late discharge cohort and likewise strongly associated with lower likelihood of early discharge in this study.
Blood transfusions are predictive of AKI and the incidence of which is estimated to be around 12% post-TAVI. 13 Bleeding events, 12 AKI, 13 and blood transfusions 12 also predict mortality post-TAVI. Avoiding vascular complications, judicious use of radiocontrast dye and avoiding prolonged intraprocedural hypotension can potentially curtail these adverse outcomes.
Stroke after TAVI is a strong predictor of mortality. 14 Similar to prior studies, 6, 7, 15 we noted stroke/TIA in 2.8% patients, significant proportion of which had prolonged hospitalization. Post-TAVI stroke was associated with significantly lower odds for early discharge in contrast to a prior analysis. 6 Over the years, incidence of stroke post-TAVI has declined owing to technological advancements valve deployment, experience, and case selection but opportunities for improvement remain. 5, 14 We found female gender to be significantly associated with lower likelihood for early discharge in a multivariate model, unlike a previous Italian study. 6 A recent study on all-female international TAVI registry 16 reported a low incidence of early mortality and stroke, yet mean length of stay was 12 days.
Mechanical circulatory support use in TAVI was noted in 10.6% of cases in a recent study on the same database. 17 Slightly lower utilization rate of 8.6% in current study may be ascribed to the exclusion of subjects with in-hospital mortality. Expectedly in this study, subjects who required mechanical circulatory support during TAVI were less likely to be discharged early. In addition, its use has been reported to predict higher mortality, length of stay, and costs. 17 Permanent pacemakers were implanted in approximately 10% of our cohort post-TAVI, in contrast to 5.9% and 16% in previous studies. 6, 7 Varied utility of balloon-expandable valve versus selfexpandable valve in these studies explains the difference in pacemaker requirements as the latter valve is associated with significantly higher conduction blocks due to mechanical impingement. [5] [6] [7] Permanent pacemaker implantation post-TAVI was significantly associated with lower rates of early discharge in current study; in contrast, the presence of a preexisting permanent pacemakers predicted higher rates of early discharge. 6, 7 Occurrence of advanced conduction blocks post-TAVI typically involves prolonged monitoring before permanent pacemaker implants are considered.
Balloon aortic valvuloplasty performed prior to TAVI was associated with higher likelihood for early discharge. Aortic valvuloplasty prior to TAVI is thought to faciliate optimal sizing and smooth deployment of transcatheter valves potentially reducing paravalvular leaks. 5, 18 However, a recent large meta-analysis involving 1395 patients showed no significant difference clinical outcomes if TAVI is performed with or without prior valvuloplasty. 18 Patients who underwent TAVI more recently fared better in terms clinical outcomes as well as early discharge rates. 5, 6 Similarly, TAVI in 2012 was significantly associated with early discharge as compared to 2011, likely owing to operator learning curves. Transfemoral TAVI was associated with higher rates of early discharge when compared to transapical approach. Our results are consistent with PARTNER trial, 19 in whom mean post-procedural length of stay after transfemoral approach was approximately 7 days while it was 12 days after a transapical approach. Additionally, transfemoral TAVI is associated with significant reduction in costs of hospitalization, 5, 19 and the costs are even lower with a minimalist approach. 20 Systematic studies and guidelines on ideal duration of post-TAVI monitoring are lacking. 7 Mean duration of hospitalization post-TAVI was three times longer in late discharge cohort in comparison to early discharge cohort in this study. Our results were comparable to prior work by Barbanti et al. 6 Early discharge rates improved from 5.6% to 50% from 2007 to 2014 in the same study. 6 With adoption of a minimalist approach for TAVI, early discharge rates are likely to improve significantly, 5 especially because there was no significant difference in adverse outcomes observed between early and late discharge cohorts at 30 days follow-up. 6, 7 Increasing hospital volume has been tied to early discharge in an earlier study on same database. 21 Home discharge and nursing home discharge rates post-TAVI are significantly higher for early discharge and late discharge cohorts, respectively.
Furthermore, financial implications of late discharge cannot be underestimated. 19, 20 Total hospitalization costs were higher by onethird, in the late discharge cohort as found in our study. We also demonstrated significant positive correlation between costs of hospitalization and post-TAVI length of stay (Fig. 5) . Avoiding unnecessary procedures and routine transfer to intensive care units for post-procedural monitoring, mitigating procedural complications, 22 universal adoption of minimalist approach unless inappropriate, conscious effort to discharge early if clinically stable can potentially curtail excessive healthcare costs involved. [5] [6] [7] 19, 20 We would like to point out few limitations of our study.
Considering the administrative nature of the NIS database, it is subject to coding limitations as we used ICD-9-CM codes to retrieve study subjects and outcomes. However, similar methods have been used extensively in prior studies. 17, 21 Overall rate of in-hospital outcomes and healthcare resource utilization should be interpreted with caution as we deliberately excluded patients who did not survive to hospital discharge. NIS database lacks information on type of transcatheter valve, surgical risk score, echocardiographic variables, degree of paravalvular leak post-TAVI, and post-discharge follow-up data, although no significant difference in clinical outcomes were noted in early discharge group at follow-up. 6, 7 Both balloon expandable and self expandable types of transcatheter aortic valves were included in our study. 21 Despite these limitations, our study depicts nationally representative real-world patient data, which is largest of its kind to date, analyzing early experience of discharge 
| CONCLUSIONS
Females, post-operative bleeding, blood transfusions, stroke, AKI, permanent pacemaker implantation, use of mechanical circulatory support were factors less likely to be associated with early discharge, whereas transfemoral approach, year of procedure, and prior aortic valvuloplasty were more likely to be associated with early discharge after TAVI. There was a strong and positive correlation between post-TAVI length of stay and hospitalization costs.
